KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for Pacira BioSciences (PCRX) over the last 13 years, with Q3 2025 value amounting to 0.02%.

  • Pacira BioSciences' Return on Invested Capital rose 900.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.08% for FY2024, which is 1300.0% down from last year.
  • According to the latest figures from Q3 2025, Pacira BioSciences' Return on Invested Capital is 0.02%, which was up 900.0% from 0.09% recorded in Q2 2025.
  • Pacira BioSciences' Return on Invested Capital's 5-year high stood at 0.34% during Q2 2021, with a 5-year trough of 0.09% in Q1 2025.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.04% (2024), whereas its average is 0.04%.
  • The largest annual percentage gain for Pacira BioSciences' Return on Invested Capital in the last 5 years was 3500bps (2021), contrasted with its biggest fall of -18700bps (2021).
  • Over the past 5 years, Pacira BioSciences' Return on Invested Capital (Quarter) stood at 0.05% in 2021, then decreased by -4bps to 0.05% in 2022, then dropped by -10bps to 0.04% in 2023, then crashed by -298bps to 0.09% in 2024, then skyrocketed by 120bps to 0.02% in 2025.
  • Its Return on Invested Capital was 0.02% in Q3 2025, compared to 0.09% in Q2 2025 and 0.09% in Q1 2025.